Composition and methods for treating ischemic wounds and inflammatory conditions
AssigneeSouthwest Technologies, Inc.
InventorsEdward I. STOUT, Chandan K. SEN
Life of this patent
Estimating the term…
Abstract
Methods, compositions, and treatment protocols for treating ischemic wounds and inflammatory conditions in a patient. The treatment protocols comprise or consist of using a modified collagen gel (MCG) to promote healing of ischemic wounds and reduce inflammation at the wound site and in other inflammatory conditions. The modified collagen gel comprises generally a dispersion of collagens in an aqueous matrix comprising water and glycerine, where the amount of Type I collagen is greater than the amount of Type II and Type III collagens in the gel.
Claims18
A method of treating an ischemic wound in a patient, said patient having an ischemic wound site said method comprising:
- applying, for a therapeutically effective period of time, a therapeutically effective amount of a modified collagen gel composition to said ischemic wound site to yield a treated ischemic wound site,
- wherein said modified collagen is a hydrolyzed bovine collagen, wherein said modified collagen gel comprises a plurality of proteins characterized by Table 1, and promotes healing of said treated ischemic wound site.
-4. (canceled)
(canceled)
(canceled)
A method of treating an inflammatory condition in a patient suffering from said inflammatory condition, said method comprising:
- administering, for a therapeutically effective period of time, a therapeutically effective amount of a modified collagen gel composition to said patient,
- wherein said modified collagen is a hydrolyzed bovine collagen, wherein said modified collagen gel comprises a plurality of proteins characterized by Table 1, and reduces the severity of said inflammatory condition in said patient.
Dependencies are inferred from the claim text.